Unknown

Dataset Information

0

Ectopic expression of anti-HIV-1 shRNAs protects CD8(+) T cells modified with CD4? CAR from HIV-1 infection and alleviates impairment of cell proliferation.


ABSTRACT: Chimeric antigen receptors (CARs) are artificially engineered receptors that confer a desired specificity to immune effector T cells. As an HIV-1-specific CAR, CD4? CAR has been extensively tested in vitro as well as in clinical trials. T cells modified with this CAR mediated highly potent anti-HIV-1 activities in vitro and were well-tolerated in vivo, but exerted limited effects on viral load and reservoir size due to poor survival and/or functionality of the transduced cells in patients. We hypothesize that ectopic expression of CD4? on CD8(+) T cells renders them susceptible to HIV-1 infection, resulting in poor survival of those cells. To test this possibility, highly purified CD8(+) T cells were genetically modified with a CD4?-encoding lentiviral vector and infected with HIV-1. CD8(+) T cells were vulnerable to HIV-1 infection upon expression of CD4? as evidenced by elevated levels of p24(Gag) in cells and culture supernatants. Concurrently, the number of CD4?-modified CD8(+) T cells was reduced relative to control cells upon HIV-1 infection. To protect these cells from HIV-1 infection, we co-expressed two anti-HIV-1 shRNAs previously developed by our group together with CD4?. This combination vector was able to suppress HIV-1 infection without impairing HIV-1-dependent effector activities of CD4?. In addition, the number of CD4?-modified CD8(+) T cells maintained similar levels to that of the control even under HIV-1 infection. These results suggest that protecting CD4?-modified CD8(+) T cells from HIV-1 infection is required for prolonged HIV-1-specific immune surveillance.

SUBMITTER: Kamata M 

PROVIDER: S-EPMC4686265 | biostudies-literature | 2015 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ectopic expression of anti-HIV-1 shRNAs protects CD8(+) T cells modified with CD4ζ CAR from HIV-1 infection and alleviates impairment of cell proliferation.

Kamata Masakazu M   Kim Patrick Y PY   Ng Hwee L HL   Ringpis Gene-Errol E GE   Kranz Emiko E   Chan Joshua J   O'Connor Sean S   Yang Otto O OO   Chen Irvin S Y IS  

Biochemical and biophysical research communications 20150519 3


Chimeric antigen receptors (CARs) are artificially engineered receptors that confer a desired specificity to immune effector T cells. As an HIV-1-specific CAR, CD4ζ CAR has been extensively tested in vitro as well as in clinical trials. T cells modified with this CAR mediated highly potent anti-HIV-1 activities in vitro and were well-tolerated in vivo, but exerted limited effects on viral load and reservoir size due to poor survival and/or functionality of the transduced cells in patients. We hy  ...[more]

Similar Datasets

| S-EPMC7335752 | biostudies-literature
| S-EPMC6453803 | biostudies-literature
| S-EPMC4887159 | biostudies-literature
| S-EPMC6944272 | biostudies-literature
| S-EPMC5079322 | biostudies-literature
| S-EPMC6375603 | biostudies-literature
| S-EPMC4207702 | biostudies-literature
| S-EPMC4445613 | biostudies-literature
2010-12-28 | E-GEOD-25456 | biostudies-arrayexpress
| S-EPMC6203616 | biostudies-literature